文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

过去二十年格雷夫斯眼眶病研究趋势:文献计量分析

Trends in Graves' orbitopathy research in the past two decades: a bibliometric analysis.

作者信息

Elubous Khaled A, Alebous Ali D, Abous Hebah A, Elubous Rawan A, Alebous Lana A, Alshammari Taher O

机构信息

Department of Ophthalmology, University of Jordan, Amman, Jordan.

Department of Surgery, King Hussein Cancer Center, Amman, Jordan.

出版信息

Arq Bras Oftalmol. 2022 Feb 14;85(6):590-598. doi: 10.5935/0004-2749.20220081. eCollection 2022.


DOI:10.5935/0004-2749.20220081
PMID:35170638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11826682/
Abstract

PURPOSE: This study was conducted to identify trends in Graves' orbitopathy research in the past two decades and to elaborate on hot topics in the field. METHODS: The Web of Science database was used to extract articles on Graves' orbitopathy or its synonyms. Full data and references were exported to VOSviewer software to be analyzed. Visualization maps and charts were constructed accordingly. RESULTS: We retrieved 1067 articles on Graves' orbitopathy from the Web of Science database. The United States ranked first in terms of the article count (25), followed by Italy (141) and the People's Republic of China (120). Wiersinga's and the University of Amsterdam's articles received the highest citation count (1509 and 3052, respectively). The University of Pisa and Thyroid published the highest number of articles (65 and 93, respectively). Co-authorship analysis showed four clusters of country collaborations: red cluster, European countries; green cluster, the United States, Brazil, Canada, South Korea, and Taiwan; a yellow cluster, People's Republic of China; and blue cluster, Japan, Australia, and Poland. Keyword analysis revealed five clusters of topics: pathogenesis, management, association, quality of life, and surgery. Analysis of co-cited references also revealed five clusters: pathogenesis, management, risk factors, clinical assessment, and surgical management. CONCLUSION: Research on Graves' orbitopathy has grown during the past two decades. Hot research topics are pathogenesis, management, risk factors, quality of life, and complications. Research trends have changed in the past two decades. Increasing interest in exploring Graves' orbitopathy mechanisms and associations is evident. European countries are cooperating in this field of research. The United States has established more extensive international cooperation than other countries. We believe that more international collaboration involving developing countries is required.

摘要

目的:本研究旨在确定过去二十年中格雷夫斯眼眶病的研究趋势,并阐述该领域的热点话题。 方法:使用科学网数据库提取关于格雷夫斯眼眶病或其同义词的文章。将完整数据和参考文献导出到VOSviewer软件进行分析。据此构建可视化地图和图表。 结果:我们从科学网数据库中检索到1067篇关于格雷夫斯眼眶病的文章。美国在文章数量方面排名第一(25篇),其次是意大利(141篇)和中华人民共和国(120篇)。维辛加和阿姆斯特丹大学的文章被引用次数最多(分别为1509次和3052次)。比萨大学和《甲状腺》杂志发表的文章数量最多(分别为65篇和93篇)。合作作者分析显示有四个国家合作集群:红色集群,欧洲国家;绿色集群,美国、巴西、加拿大、韩国和台湾;黄色集群,中华人民共和国;蓝色集群,日本、澳大利亚和波兰。关键词分析揭示了五个主题集群:发病机制、治疗、关联、生活质量和手术。共被引参考文献分析也揭示了五个集群:发病机制、治疗、危险因素、临床评估和手术治疗。 结论:在过去二十年中,格雷夫斯眼眶病的研究有所增长。热门研究主题是发病机制、治疗、危险因素、生活质量和并发症。在过去二十年中研究趋势发生了变化。对探索格雷夫斯眼眶病机制和关联的兴趣明显增加。欧洲国家在该研究领域开展合作。美国比其他国家建立了更广泛的国际合作。我们认为需要更多涉及发展中国家的国际合作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ec/11826682/abbf28cf5225/abo-85-06-0590-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ec/11826682/4ae269843ba3/abo-85-06-0590-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ec/11826682/786eb4750990/abo-85-06-0590-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ec/11826682/854cfc6b3147/abo-85-06-0590-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ec/11826682/22f397fc22fa/abo-85-06-0590-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ec/11826682/abbf28cf5225/abo-85-06-0590-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ec/11826682/4ae269843ba3/abo-85-06-0590-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ec/11826682/786eb4750990/abo-85-06-0590-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ec/11826682/854cfc6b3147/abo-85-06-0590-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ec/11826682/22f397fc22fa/abo-85-06-0590-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ec/11826682/abbf28cf5225/abo-85-06-0590-g05.jpg

相似文献

[1]
Trends in Graves' orbitopathy research in the past two decades: a bibliometric analysis.

Arq Bras Oftalmol. 2022-2-14

[2]
Global research landscape and emerging trends in Graves' disease: A bibliometric analysis.

Medicine (Baltimore). 2024-6-14

[3]
Gut microbiota and eye diseases: a bibliometric study and visualization analysis.

Front Cell Infect Microbiol. 2023

[4]
Survey of common practices among oculofacial surgeons in the Asia-Pacific region: Graves' orbitopathy.

Orbit. 2014-10

[5]
Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.

Clin Endocrinol (Oxf). 2018-11-19

[6]
Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre study.

J Endocrinol Invest. 2020-12

[7]
Natural history of graves' orbitopathy after treatment.

Endocrine. 2017-8

[8]
Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z uwzględnieniem zaleceń European Group on Graves' Orbitopathy (EUGOGO)].

Endokrynol Pol. 2022

[9]
Optimal management of Graves orbitopathy: a multidisciplinary approach.

Neth J Med. 2011

[10]
Emerging Insights in Thyroid Eye Disease Research from 2010 to 2022: Trends, Hot Spots, and Research Situation.

Semin Ophthalmol. 2025-4-14

引用本文的文献

[1]
Bibliometrics in thyroid eye disease.

J Endocrinol Invest. 2025-8-29

[2]
Global research landscape and emerging trends in Graves' disease: A bibliometric analysis.

Medicine (Baltimore). 2024-6-14

本文引用的文献

[1]
Teprotumumab: First Approval.

Drugs. 2020-4

[2]
Teprotumumab for the Treatment of Active Thyroid Eye Disease.

N Engl J Med. 2020-1-23

[3]
Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis.

Eye (Lond). 2018-12-21

[4]
The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy.

Eye (Lond). 2018-12-7

[5]
Thyroid eye disease: what is new to know?

Curr Opin Ophthalmol. 2018-11

[6]
Quality of life and neuropsychiatric disorders in patients with Graves' Orbitopathy: Current concepts.

Autoimmun Rev. 2018-5-2

[7]
Fair ranking of researchers and research teams.

PLoS One. 2018-4-5

[8]
Document co-citation analysis to enhance transdisciplinary research.

Sci Adv. 2018-1-3

[9]
International publication trends in dry eye disease research: A bibliometric analysis.

Ocul Surf. 2017-10-12

[10]
Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface.

Clin Diabetes Endocrinol. 2016-11-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索